Eric Staeva-Vieira, PhD

Columnist: Eric Staeva-Vieira, PhD

 

 

Eric Staeva-Vieira, PhD, is a Vice President / Senior Pharma & Biotech Analyst for Majestic Research, an independent equity research firm on Wall Street. Before joining Majestic, Eric worked as a biotech analyst on the traditional sell-side for Lazard Capital Markets and Rodman & Renshaw, both healthcare-oriented investment banks. Prior to his move on Wall Street, Eric was the program manager of the New York Academy of Sciences’ Science Alliance, a career and professional development program for scientists.  In 2003, he received his PhD in developmental genetics from New York University.  His research focused on the link between genome stability and development using the Drosophila melanogaster, more commonly known as the fruit fly.